✦ LIBER ✦

Elevated serum levels of macrophage colony stimulating factor during interferon-$alpha; therapy for chronic hepatitis C

✍ Scribed by ITOH, Y

Book ID: 122902084
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 322 KB
Volume: 2
Category: Article
ISSN: 0928-4346
DOI: 10.1016/0928-4346(94)90050-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon α treatment of chronic hepatitis c

✍ Vicente Carreño; Vicente Carreño; Adolfo Parra; Sonia Navas; Antonio Juan Quirog 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Interferon alpha-2b alone or combined wi

Interferon alpha-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis C

✍ Karin Groenbaek; Henrik Krarup; Helmer Ring-Larsen; Ove Schaffalitzsky de Muckad 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Use of granulocyte macrophage colony sti

Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C

✍ Mitchell L. Shiffman; Charlotte M. Hofmann; Velimir A. Luketic; Arun J. Sanyal 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Possible mechanisms of elevation of seru

Possible mechanisms of elevation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients

✍ Kenji Fujimori; Satoshi Mochida; Atsushi Matsui; Akihiko Ohno; Kenji Fujiwara 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 411 KB

Retinal complications and plasma C5a lev

Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C

✍ Shigeo Sugano; Tokuya Suzuki; Manabu Watanabe; Kenji Ohe; Kunihiko Ishii; Tugio 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

Treatment of chronic hepatitis C with ci

Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha

✍ Margarita Pardo; Inmaculada Castillo; Sonia Navas; Dr. Vicente Carreño 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Interferon therapy in cirrhotic patients with hepatitis C virus infection is not efficient. In an at- tempt t o improve the response rate, a pilot study using recombinant human granulocyte colonystimulating factor (rhG-CSF) alone, and in combination with recombinant interferon-alpha (rlFN), was carr